Form 4: Hims & Hers CMO Executes RSU Vesting and Tax Withholding
Statement of Changes in Beneficial Ownership
Chief Medical Officer Patrick Harrison Carroll acquired 25,926 shares of Hims & Hers Health, Inc. through RSU vesting, with 8,310 shares withheld for taxes.
Summary
- Chief Medical Officer Patrick Harrison Carroll exercised and settled Restricted Stock Units (RSUs) on June 15, 2026.
- A total of 25,926 shares of Class A Common Stock were acquired upon the vesting of multiple RSU tranches.
- The company withheld 8,310 shares at a price of $30.17 per share to satisfy mandatory tax withholding obligations.
- Following these transactions, the reporting person holds a total of 205,587 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents routine administrative equity vesting rather than a discretionary change in the executive's investment position.
Positives
- The transaction reflects the standard vesting of equity compensation, aligning the interests of the Chief Medical Officer with long-term shareholder value.
Negatives
- The transaction involved a mandatory sell-to-cover event, which is a standard administrative procedure for tax obligations rather than a discretionary market sale.
Risks
- No specific operational or financial risks are disclosed in this regulatory filing.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a disclosure of insider equity transactions.
Industry Context
StockSavvy.ai notes that this filing is a routine disclosure of executive compensation vesting, which is common practice for publicly traded companies in the telehealth and consumer health sectors to maintain transparency regarding insider holdings.
Comparison to Industry Standards
- The use of sell-to-cover transactions for tax withholding is standard practice among U.S. public companies to manage executive tax liabilities during equity vesting cycles.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a standard component of executive compensation packages.
Next Steps
- Continued service-based vesting of remaining RSU tranches as per the established 4-year schedules.
Key Dates
| Date | Description |
|---|---|
| 06/15/2026 | Date of RSU vesting and transaction execution. |
| 06/17/2026 | Date of filing for the reported transactions. |
Keywords
Hims & Hers, HIMS, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units, Chief Medical Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.